BIOMAT Database Logo BIOMAT Database Logo

[Detection of anti-HCV antibodies in patients on long-term hemodialysis]. 2000

N Vasiljević, and J Taseski

Hepatitis C virus (HCV) infection is highly prevalent among chronic dialysis patients and is the most common cause of chronic liver disease. Ninety six patients on chronic hemodialysis in our institute of transfusiology at the Military Medical Academy were evaluated for the presence of HCV infection. There was a significant relationship between presence of anti-HCV antibodies and number of blood transfusion received by examined patients. We concluded that hepatitis C is a common problem among patients on chronic hemodialysis in our institution: HCV infection is proved in about 48.95% of all patients on hemodialysis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D018937 Hepatitis C Antibodies Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins. Anti-HCV Antibodies,Anti-Hepatitis C Virus Antibodies,HCV Antibodies,Hepatitis C Virus Antibodies,Anti HCV Antibodies,Anti Hepatitis C Virus Antibodies

Related Publications

N Vasiljević, and J Taseski
Prevalence of anti-HCV in patients on long-term hemodialysis.
March 1990, Nihon Jinzo Gakkai shi,
N Vasiljević, and J Taseski
[Occurrence of antibodies against hepatitis C virus (anti-HCV) in patients on long-term hemodialysis].
January 1992, Przeglad lekarski,
N Vasiljević, and J Taseski
[Study on serum anti-HCV antibodies in hemodialysis patients].
January 1994, Zhonghua hu li za zhi = Chinese journal of nursing,
N Vasiljević, and J Taseski
The prevalence of anti-HCV antibodies in hemodialysis patients.
July 1991, Gastroenterologia Japonica,
N Vasiljević, and J Taseski
Anti-Toxoplasma gondii antibodies in hemodialysis patients receiving long-term hemodialysis therapy in Turkey.
September 2005, Saudi medical journal,
N Vasiljević, and J Taseski
[The prevalence of anti-HCV antibodies in a population of Sicilian hemodialysis patients].
September 1994, Recenti progressi in medicina,
N Vasiljević, and J Taseski
Antibodies to DNA in patients undergoing long-term hemodialysis.
December 1980, Clinical nephrology,
N Vasiljević, and J Taseski
Detection of Anti-GOR Antibodies in HCV Infection.
January 1999, Methods in molecular medicine,
N Vasiljević, and J Taseski
The prevalence of HCV RNA positivity in anti-HCV antibodies-negative hemodialysis patients in Thrace Region. Multicentral study.
March 2021, Germs,
N Vasiljević, and J Taseski
Association of HCV core antigen seropositivity with long-term mortality in patients on regular hemodialysis.
January 2012, Nephron extra,
Copied contents to your clipboard!